Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Pharmaron Beijing Co., Ltd.
  6. News
  7. Summary
    300759   CNE100003JW4

PHARMARON BEIJING CO., LTD.

(300759)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pharmaron Beijing Raising $600 Million From Sale of Renminbi, US Dollar Convertible Bonds

06/08/2021 | 09:35pm EDT


ę MT Newswires 2021
All news about PHARMARON BEIJING CO., LTD.
08/29Pharmaron Beijing Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2..
CI
07/15Pharmaron Beijing Co., Ltd. Provides Earnings Guidance for the Interim Period Ended Jun..
CI
06/20PHARMARON BEIJING : Files for Hong Kong Bourse Listing of Renminbi, US Dollar Bonds
MT
06/09PHARMARON BEIJING : Proposes Reduction of Registered Capital
MT
06/08Pharmaron Beijing Raising $600 Million From Sale of Renminbi, US Dollar Convertible Bon..
MT
05/31Pharmaron Beijing Co., Ltd. Approves Cash Dividend for the Year 2020, Payable on 30 Jun..
CI
05/13MSCI Adds Ganfeng Lithium, Ningxia Baofeng to Global Emerging Markets Index Under Revam..
MT
04/30PHARMARON BEIJING : Closure of register of members for the first h shares class meeting of..
PU
04/29PHARMARON BEIJING : First Quarter Profit Rockets 142%, Revenue Soars
MT
04/28PHARMARON BEIJING : Reply Slip for the First H Shares Class Meeting of 2021
PU
More news
Financials
Sales 2021 7 085 M 1 095 M 1 095 M
Net income 2021 1 461 M 226 M 226 M
Net cash 2021 3 366 M 520 M 520 M
P/E ratio 2021 120x
Yield 2021 0,17%
Capitalization 166 B 25 723 M 25 702 M
EV / Sales 2021 23,0x
EV / Sales 2022 17,3x
Nbr of Employees -
Free-Float 71,1%
Chart PHARMARON BEIJING CO., LTD.
Duration : Period :
Pharmaron Beijing Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHARMARON BEIJING CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 221,01 CNY
Average target price 200,74 CNY
Spread / Average Target -9,17%
EPS Revisions
Managers and Directors
Bo Liang Lou Chairman & Chief Executive Officer
Shing Chung Li Chief Financial Officer & Board Secretary
Kexin Yang Chairman-Supervisory Board & Vice President
Hua Yang Chief Scientific Officer
Xiao Qiang Lou Chief Operating Officer & Executive Director
Sector and Competitors
1st jan.Capi. (M$)
PHARMARON BEIJING CO., LTD.83.56%25 723
MODERNA, INC.315.47%170 876
LONZA GROUP AG31.58%59 927
IQVIA HOLDINGS INC.43.03%48 510
CELLTRION, INC.-23.26%31 691
SEAGEN INC.-5.78%28 939